| LABCORP HLDGS INC. O.N. |
| USA |
| Gesundheit |
| US5049221055 / A40C39 |
| N6B (Frankfurt) / LH (NYSE) |
| FRA:N6B, ETR:N6B, N6B:GR, NYSE:LH |
| - |
| https://www.labcorp.com/ |
|
Labcorp Holdings Inc. operates as a company providing comprehensive laboratory services across a variety of health disciplines. As a leader in diagnostic testing, Labcorp offers an extensive range of ..
>Volltext.. |
| 19425.31 Mio. EUR |
| 24494.55 Mio. EUR |
| 11597.98 Mio. EUR |
| 1721.84 Mio. EUR |
| 720.55 Mio. EUR |
| 8.64 EUR |
| 5501.78 Mio. EUR |
| 503.93 Mio. EUR |
| 1519.54 Mio. EUR |
| 0.23 |
| 2.74% |
| 86.33% |
| 2.48 EUR |
| 1.02% |
| 1.04% |
| 26.11.25 - 0.621864€ 28.08.25 - 0.61776€ >weitere anzeigen... |
| LABCORP |
| 17.02.26 |
|
||||
|
||||
|
||||
|